Wiz binds active promoters and CTCF-binding sites and is required for normal behaviour in the mouse

  1. Luke Isbel
  2. Lexie Prokopuk
  3. Haoyu Wu
  4. Lucia Daxinger
  5. Harald Oey
  6. Alex Spurling
  7. Adam J Lawther
  8. Matthew W Hale
  9. Emma Whitelaw  Is a corresponding author
  1. La Trobe Institute for Molecular Science, Australia
  2. Hudson Institute of Medical Research, Australia
  3. Leiden University Medical Centre, Netherlands
  4. University of Queensland Diamantina Institute, Australia
  5. La Trobe University, Australia

Abstract

We previously identified Wiz in a mouse screen for epigenetic modifiers. Due to its known association with G9a/GLP, Wiz is generally considered a transcriptional repressor. Here we provide evidence that it may also function as a transcriptional activator. Wiz levels are high in brain but its function and direct targets are unknown. ChIP-seq was performed in adult cerebellum and Wiz peaks were found at promoters and transcription factor CTCF binding sites. RNA-seq in Wiz mutant mice identified genes differentially regulated in adult cerebellum and embryonic brain. In embryonic brain most decreased in expression and included clustered protocadherin genes. These also decreased in adult cerebellum and showed strong Wiz ChIP-seq enrichment. Because a precise pattern of protocadherin gene expression is required for neuronal development, behavioural tests were carried out on mutant mice, revealing an anxiety-like phenotype. This is the first evidence of a role for Wiz in neural function.

Data availability

The following data sets were generated
The following previously published data sets were used
    1. Bian C
    2. Chen Q
    3. Yu X
    (2015) G9a, ZNF644 and WIZ ChIP-seq results
    Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE62616).

Article and author information

Author details

  1. Luke Isbel

    Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5270-4347
  2. Lexie Prokopuk

    Centre for Genetic Diseases, Hudson Institute of Medical Research, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Haoyu Wu

    Department of Human Genetics, Leiden University Medical Centre, Leiden, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  4. Lucia Daxinger

    Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Harald Oey

    Translational Research Institute, University of Queensland Diamantina Institute, Brisbane, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Alex Spurling

    Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4368-6191
  7. Adam J Lawther

    Department of Psychology and Counselling, La Trobe University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Matthew W Hale

    Department of Psychology and Counselling, La Trobe University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Emma Whitelaw

    Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Melbourne, Australia
    For correspondence
    e.whitelaw@latrobe.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2320-2903

Ethics

Animal experimentation: All animal work was conducted in accordance with the Australian code for the care and use of animals for scientific purposes, this study was approved by the Animal Ethics Committee of La Trobe University, project numbers 12-74, 12-75, 15-01.

Copyright

© 2016, Isbel et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,684
    views
  • 574
    downloads
  • 21
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Luke Isbel
  2. Lexie Prokopuk
  3. Haoyu Wu
  4. Lucia Daxinger
  5. Harald Oey
  6. Alex Spurling
  7. Adam J Lawther
  8. Matthew W Hale
  9. Emma Whitelaw
(2016)
Wiz binds active promoters and CTCF-binding sites and is required for normal behaviour in the mouse
eLife 5:e15082.
https://doi.org/10.7554/eLife.15082

Share this article

https://doi.org/10.7554/eLife.15082

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Steven Henikoff, David L Levens
    Insight

    A new method for mapping torsion provides insights into the ways that the genome responds to the torsion generated by RNA polymerase II.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bhumil Patel, Maryke Grobler ... Needhi Bhalla
    Research Article

    Meiotic crossover recombination is essential for both accurate chromosome segregation and the generation of new haplotypes for natural selection to act upon. This requirement is known as crossover assurance and is one example of crossover control. While the conserved role of the ATPase, PCH-2, during meiotic prophase has been enigmatic, a universal phenotype when pch-2 or its orthologs are mutated is a change in the number and distribution of meiotic crossovers. Here, we show that PCH-2 controls the number and distribution of crossovers by antagonizing their formation. This antagonism produces different effects at different stages of meiotic prophase: early in meiotic prophase, PCH-2 prevents double-strand breaks from becoming crossover-eligible intermediates, limiting crossover formation at sites of initial double-strand break formation and homolog interactions. Later in meiotic prophase, PCH-2 winnows the number of crossover-eligible intermediates, contributing to the designation of crossovers and ultimately, crossover assurance. We also demonstrate that PCH-2 accomplishes this regulation through the meiotic HORMAD, HIM-3. Our data strongly support a model in which PCH-2’s conserved role is to remodel meiotic HORMADs throughout meiotic prophase to destabilize crossover-eligible precursors and coordinate meiotic recombination with synapsis, ensuring the progressive implementation of meiotic recombination and explaining its function in the pachytene checkpoint and crossover control.